Journal of Preventive Medicine and Public Health

The Korean Society for Preventive Medicine (대한예방의학회)
권호 표지

Socioeconomic Costs of Stroke in Korea: Estimated from the Korea National Health Insurance Claims Database

건강보험 청구자료를 이용한 우리나라 뇌졸증 환자의 사회경제적 비용 추계

  • Lim, Seung-Ji (Department of Public Health, Yonsei University Graduate School) ;
  • Kim, Han-Joong (Department of Preventive Medicine and Public Health, Yonsei University College of Medicine) ;
  • Nam, Chung-Mo (Department of Preventive Medicine and Public Health, Yonsei University College of Medicine) ;
  • Chang, Hoo-Sun (Graduate School of Public Health, Yonsei University) ;
  • Jang, Young-Hwa (Department of Public Health, Yonsei University Graduate School) ;
  • Kim, Se-Ra (Health Insurance Review and Assessment Service) ;
  • Kang, Hye-Young (Graduate School of Public Health, Yonsei University)
  • 임승지 (연세대학교 대학원 보건학과) ;
  • 김한중 (연세대학교 의과대학 예방의학교실) ;
  • 남정모 (연세대학교 의과대학 예방의학교실) ;
  • 장후선 (연세대학교 보건대학원) ;
  • 장영화 (연세대학교 대학원 보건학과) ;
  • 김세라 (연세대학교 보건정책 및 관리연구소) ;
  • 강혜영 (연세대학교 보건대학원)
  • Published : 2009.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : To estimate the annual socioeconomic costs of stroke in Korea in 2005 from a societal perspective. Methods : We identified those 20 years or older who had at least one national health insurance (NHI) claims record with a primary or a secondary diagnosis of stroke (ICD-10 codes: I60-I69, G45) in 2005. Direct medical costs of the stroke were measured from the NHI claims records. Direct non-medical costs were estimated as transportation costs incurred when visiting the hospitals. Indirect costs were defined as patients and caregivers productivity loss associated with office visits or hospitalization. Also, the costs of productivity loss due to premature death from stroke were calculated. Results : A total of 882,143 stroke patients were identified with prevalence for treatment of stroke at 2.44%. The total cost for the treatment of stroke in the nation was estimated to be 3,737 billion Korean won (KRW) which included direct costs at 1,130 billion KRW and indirect costs at 2,606 billion KRW. The per-capita cost of stroke was 3 million KRW for men and 2 million KRW for women. The total national spending for hemorrhagic and ischemic stroke was 1,323 billion KRW and 1,553 billion KRW, respectively, which together consisted of 77.0% of the total cost for stroke. Costs per patient for hemorrhagic and ischemic stroke were estimated at 6 million KRW and 2 million KRW, respectively. Conclusions : Stroke is a leading public health problem in Korea in terms of the economic burden. The indirect costs were identified as the largest component of the overall cost.

Keywords

References

  1. Korea National Statistical Office. Report on Death Causes 2005. Daejeon: Korea National Statistical Office; 2006. (Korean)
  2. Luengo-Fernandez R, Leal J, Gray A, Petersen S, Rayner M. The cost of cardiovascular diseases in the United Kingdom. Heart 2006; 92(10): 1384-1389 https://doi.org/10.1136/hrt.2005.072173
  3. Leal J, Luengo-Fernandez R, Gray A, Petersen S, Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J 2006; 27(13): 1610-1619 https://doi.org/10.1093/eurheartj/ehi733
  4. Paul SL, Srikanth VK, Thrift AG. The large and growing burden of stroke. Curr Drug Targets 2007; 8(7): 786-793 https://doi.org/10.2174/138945007781077418
  5. World Health Organization. World Health Report 2004. Geneva: World Health Organization; 2004
  6. Korea National Statistical Office. Report on the Social Statistics Survey 2005. Daejeon: Korea National Statistical Office; 2006. (Korean)
  7. Council of the European Union. 2586th Council Meeting-Employment, Social Policy, Health and Consumer Affairs. Brussels: Council of the European Union; 2004
  8. Kim SH, Lee YS, Lee SM, Yoon BW, Park BJ. Body mass index and risk of hemorrhagic stroke in Korean adults: Case-control study. J Prev Med Public Health 2007; 40(4): 313-320. (Korean) https://doi.org/10.3961/jpmph.2007.40.4.313
  9. Matchar DB, Samsa GP, Liu S. Costeffectiveness of antiplatelet agents in secondary stroke prevention: The limits of certainty. Value Health 2005; 8(5): 572-580 https://doi.org/10.1111/j.1524-4733.2005.00050.x
  10. Matchar DB, Duncan PW. Cost of stroke. Stroke Clin Updates 1994; 5(3): 9-12
  11. Taylor TN, Davis PH, Torner JC, Holmes J, Meyer JW, Jacobson MF. Lifetime cost of stroke in the United States. Stroke 1996; 27(9): 1459-1466 https://doi.org/10.1161/01.STR.27.9.1459
  12. Terent A, Marke LA, Asplund K, Norrving B, Jonsson E, Wester PO. Costs of stroke in Sweden: A national perspective. Stroke 1994; 25(12): 2363-2369 https://doi.org/10.1161/01.STR.25.12.2363
  13. Persson U, Silverberg R, Lindgren B, Norrving B, Jadback G, Johansson B, et al. Direct costs of stroke for a Swedish population. Int J Technol Assess Health Care 1990; 6(1): 125-137 https://doi.org/10.1017/S0266462300008989
  14. Chan B, Hayes B. Cost of stroke in Ontario, 1994-1995. CMAJ 1998; 159(6 suppl): S2-S7
  15. Evers SM, Engel GL, Ament AJ. Cost of stroke in The Netherlands from a societal perspective. Stroke 1997; 28(7): 1375-1381 https://doi.org/10.1161/01.STR.28.7.1375
  16. Bergman L, van der Meulen JH, Limburg M, Habbema JD. Costs of medical care after firstever stroke in The Netherlands. Stroke 1995; 26(10): 1830-1836 https://doi.org/10.1161/01.STR.26.10.1830
  17. Isard PA, Forbes JF. The cost of stroke to the national health service in Scotland. Cerebrovasc Dis 1992; 2(1): 47-50 https://doi.org/10.1159/000108988
  18. Scott WG, Scott H. Ischaemic stroke in New Zealand: An economic study. N Z Med J 1994; 107(989): 443-446
  19. Rossnagel K, Nolte CH, Muller-Nordhorn J, Jungehulsing GJ, Selim D, Bruggenjurgen B, et al. Medical resource use and costs of health care after acute stroke in Germany. Eur J Neurol 2005; 12(11): 862-868 https://doi.org/10.1111/j.1468-1331.2005.01091.x
  20. Dodel RC, Haacke C, Zamzow K, Paweilik S, Spottke A, Rethfeldt M, et al. Resource utilization and costs of stroke unit care in Germany. Value Health 2004; 7(2): 144-152 https://doi.org/10.1111/j.1524-4733.2004.72314.x
  21. Yoneda Y, Okuda S, Hamada R, Toyota A, Gotoh J, Watanabe M, et al. Hospital cost of ischemic stroke and intracerebral hemorrhage in Japanese stroke centers. Health Policy 2005; 73(2): 202-211 https://doi.org/10.1016/j.healthpol.2004.11.016
  22. Rice D. Cost-of-illness studies: Fact or fiction. Lancet 1994; 344(8936): 1519-1520 https://doi.org/10.1016/S0140-6736(94)90342-5
  23. Chung W, Chun H, Lee S. Socioeconomic costs of alcohol drinking in Korea. J Prev Med Public Health 2006; 39(1): 21-29. (Korean)
  24. Kang HY, Kim HJ, Park TK, Jee SH, Nam CM, Park HW. Economic burden of smoking in Korea. Tob Control 2003; 12(1): 37-44 https://doi.org/10.1136/tc.12.1.37
  25. Park C, Kang H, Kwon I, Kang D, Jung H. Cost-of-illness Study of asthma in Korea: Estimated from the Korea National Health Insurance Claims Database. J Prev Med Public Health 2006; 39(5): 397-403. (Korean)
  26. Chang SM, Cho SJ, Jeon HJ, Hahm BJ, Lee HJ, Park JI, et al. Economic burden of schizophrenia in South Korea. J Korean Med Sci 2008; 23(2): 167-175. (Korean) https://doi.org/10.3346/jkms.2008.23.2.167
  27. Chung YH, Ko SJ. Estimating socioeconomic costs of five major diseases. Korean J Public Finance 2004; 18(2): 77-104. (Korean)
  28. National Health Insurance Corporation. 2005 Survey on National Health Insurance Patients Out-of-pocket Expenditure. Seoul: National Health Insurance Corporation; 2006. (Korean)
  29. Korea National Statistical Office. Yearbook of Labor Statistics 2005. Daejeon: Korea National Statistical Office; 2006. (Korean)
  30. Korea Ministry of Labor. Statistics for Wage Structure 2005. Gwacheon: Korea Ministry of Labor; 2006. (Korean)
  31. Korea National Statistical Office. Life time table. Daejeon: Korea National Statistical Office; [cited 2009 May 5]. Available from: URL:http: //kosis.nso.go.kr. (Korean)
  32. Drummond M, O Brien B, Stoddart G, Torrance G. Methods for the Economic Evaluation of Health Care Program. New York: Oxford University Press; 1997
  33. Korea National Statistical Office. Age-andgender-specific Population Size 2005. Daejeon: Korea National Statistical Office; 2006. (Korean)
  34. Organization for Economic Co-operation and Development. OECD Health Data 2008: Statistics and Indicators for 30 Countries. Paris: Organization for Economic Co-operation and Development; 2008
  35. Barrett-Connor E. The economic and human costs of osteoporotic fracture. Am J Med 1995; 98(2A): 3S-8S https://doi.org/10.1016/S0002-9343(05)80037-3
  36. Kang S, Jeong J, Moon B, Kim J. Current epidemiological status of cerebrovascular disease. J Korean Neurosurg Soc 1999; 28(4): 509-513. (Korean)
  37. Feigin VL, Wiebers DO, Nikitin YP, O Fallon WM, Whisnant JP. Stroke epidemiology in Novosibirsk, Russia: A population-based study. Mayo Clin Proc 1995; 70(9): 847-852 https://doi.org/10.4065/70.9.847
  38. Hodgson TA, Cai L. Medical care expenditures for hypertension, its complications, and its comorbidities. Med Care 2001; 39(6): 599-615 https://doi.org/10.1097/00005650-200106000-00008
  39. Arredondo A, Zuniga A. Epidemiologic changes and economic burden of hypertension in Latin America: Evidence from Mexico. Am J Hypertens 2006; 19(6): 553-559 https://doi.org/10.1016/j.amjhyper.2005.10.028
  40. Lee KS, Bae HJ, Kim HS. Utilization of health care resources and costs of stroke patients: Patients perspective. J Korean Neurol Assoc 2004; 22(6): 583-589. (Korean)